NEW YORK (Reuters Health) – Most oral anticancer drugs require prior authorization and this often leads to delays in obtaining the medication, a new study indicates.
“New health policies are...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok